Vitrolife AB Statistics

Total Valuation

Vitrolife AB has a market cap or net worth of 1.93 billion. The enterprise value is 2.02 billion.

Market Cap	1.93B
Enterprise Value	2.02B

Important Dates

The next estimated earnings date is Thursday, July 17, 2025.

Earnings Date	Jul 17, 2025
Ex-Dividend Date	May 2, 2025

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.10%
Shares Change (QoQ)	-0.21%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	75.04M

Valuation Ratios

The trailing PE ratio is 38.84 and the forward PE ratio is 32.76.

PE Ratio	38.84
Forward PE	32.76
PS Ratio	5.36
PB Ratio	1.47
P/TBV Ratio	n/a
P/FCF Ratio	28.24
P/OCF Ratio	24.86
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.00, with an EV/FCF ratio of 29.62.

EV / Earnings	40.75
EV / Sales	5.32
EV / EBITDA	16.00
EV / EBIT	24.83
EV / FCF	29.62

Financial Position

The company has a current ratio of 3.77, with a Debt / Equity ratio of 0.15.

Current Ratio	3.77
Quick Ratio	2.98
Debt / Equity	0.15
Debt / EBITDA	1.62
Debt / FCF	2.85
Interest Coverage	8.41

Financial Efficiency

Return on equity (ROE) is 3.78% and return on invested capital (ROIC) is 3.18%.

Return on Equity (ROE)	3.78%
Return on Assets (ROA)	2.89%
Return on Invested Capital (ROIC)	3.18%
Return on Capital Employed (ROCE)	4.83%
Revenue Per Employee	312,731
Profits Per Employee	43,141
Employee Count	1,169
Asset Turnover	0.22
Inventory Turnover	3.64

Taxes

In the past 12 months, Vitrolife AB has paid 17.23 million in taxes.

Income Tax	17.23M
Effective Tax Rate	25.78%

Stock Price Statistics

The stock price has increased by +12.03% in the last 52 weeks. The beta is 1.80, so Vitrolife AB's price volatility has been higher than the market average.

Beta (5Y)	1.80
52-Week Price Change	+12.03%
50-Day Moving Average	16.58
200-Day Moving Average	19.60
Relative Strength Index (RSI)	21.79
Average Volume (20 Days)	13

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Vitrolife AB had revenue of 359.64 million and earned 49.61 million in profits. Earnings per share was 0.37.

Revenue	359.64M
Gross Profit	213.39M
Operating Income	77.11M
Pretax Income	66.85M
Net Income	49.61M
EBITDA	114.77M
EBIT	77.11M
Earnings Per Share (EPS)	0.37

Full Income Statement

Balance Sheet

The company has 105.00 million in cash and 194.37 million in debt, giving a net cash position of -89.36 million.

Cash & Cash Equivalents	105.00M
Total Debt	194.37M
Net Cash	-89.36M
Net Cash Per Share	n/a
Equity (Book Value)	1.31B
Book Value Per Share	9.66
Working Capital	166.77M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 77.51 million and capital expenditures -9.26 million, giving a free cash flow of 68.24 million.

Operating Cash Flow	77.51M
Capital Expenditures	-9.26M
Free Cash Flow	68.24M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 59.34%, with operating and profit margins of 21.44% and 13.80%.

Gross Margin	59.34%
Operating Margin	21.44%
Pretax Margin	18.59%
Profit Margin	13.80%
EBITDA Margin	31.91%
EBIT Margin	21.44%
FCF Margin	18.98%

Dividends & Yields

This stock pays an annual dividend of 0.07, which amounts to a dividend yield of 0.46%.

Dividend Per Share	0.07
Dividend Yield	0.46%
Dividend Growth (YoY)	25.81%
Years of Dividend Growth	2
Payout Ratio	27.11%
Buyback Yield	-0.10%
Shareholder Yield	0.37%
Earnings Yield	2.57%
FCF Yield	3.54%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

The last stock split was on June 1, 2018. It was a forward split with a ratio of 1.25.

Last Split Date	Jun 1, 2018
Split Type	Forward
Split Ratio	1.25

Scores

Vitrolife AB has an Altman Z-Score of 5.17 and a Piotroski F-Score of 8.

Altman Z-Score	5.17
Piotroski F-Score	8